Relation of Recurrence of Atrial Fibrillation After Successful Cardioversion to Renal Function

American Journal of Cardiology

Volumn 105, Issue 3, 2010, Pages 368-372

  Schmidt, Martin ^a   Rieber, Johannes ^b   Daccarett, Marcos ^c   Marschang, Harald ^a   Sinha, Anil Martin ^a   Biggar, Patrick ^a   Jung, Philip ^b   Ketteler, Markus ^a   Brachmann, Johannes ^a   Rittger, Harald ^a  

^a KLINIKUM COBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CARDIOVERSION; DEFIBRILLATOR; DIABETES MELLITUS; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HOLTER MONITORING; HYPERLIPIDEMIA; HYPERTENSION; INTERVIEW; KIDNEY FUNCTION; PRIORITY JOURNAL; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART CONDUCTION SYSTEM; HUMANS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECURRENCE; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 74249085424     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.09.037     Document Type: Article

References (25)

1. Iguchi Y., Kimura K., Kobayashi K., Aoki J., Terasawa Y., Sakai K., Uemura J., and Shibazaki K. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol 102 (2008) 1056-1059
2. Vazquez E., Sanchez-Perales C., Borrego F., Garcia-Cortes M.J., Lozano C., Guzman M., Gil J.M., Borrego M.J., and Përez V. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 140 (2000) 886-890
3. Abbott K.C., Trespalacios F.C., Taylor A.J., and Agodoa L.Y. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol 4 (2003) 1-10
4. Zebe H. Atrial fibrillation in dialysis patients. Nephrol Dial Transplant 15 (2000) 765-768
5. McCullough P.A., Soman S.S., Shah S.S., Smith S.T., Marks K.R., Yee J., and Borzak S. Risks associated with renal dysfunction in the coronary care unit. J Am Coll Cardiol 36 (2000) 679-684
6. Fuster V., Rydén L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Halperin J.L., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Tamargo J.L., Zamorano J.L., American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, and European Heart Rhythm AssociationHeart Rhythm Society. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: full text: a report of the American College/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8 (2006) 651-745
7. Stabile G., Berteglia E., Turco P., Zoppo F., Iuliano A., Zerbo F., La Rocca V., and De Simone A. Role of pulmonary veins isolation in persistent atrial fibrillation ablation: the pulmonary vein isolation in persistent atrial fibrillation (PIPA) study. Pacing Clin Electrophysiol 32 suppl 1 (2009) 116-119
8. Chun K.-R.J., Schmidt B., Metzner A., Tilz R., Zerm T., Köster I., Fürnkranz A., Koektuerk B., Konstantinidou M., Antz M., Ouyang F., and Kuck K.H. The "single big cryoballoon" technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J 30 (2009) 699-709
9. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
10. Kang Y.S., Han K.A., Han S.Y., Kim H.K., and Cha D.R. Characteristics of population with normal serum creatinine impaired renal function and: the validation of a MDRD formula in a healthy general population. Clin Nephrol 63 (2005) 258-266
11. Levey A.S., Eckardt K.U., Tsukamoto Y., Levin A., Coresh J., Rossert J., De Zeeuw D., Hostetter T.H., Lameire N., and Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
12. Guyton A.C. The surprising kidney-fluid mechanism for pressure control-its infinite gain!. Hypertension 16 (1990) 725-730
13. Bongartz L.G., Cramer M.J., Doevendans P.A., Joles J.A., and Braam B. The severe cardiorenal syndrome: "Guyton revisited". Review. Eur Heart J 26 (2005) 11-17
14. Henry R.M., Kostense P.J., Bos G., Dekker J.M., Nijpels G., Heine R.J., Bouter L.M., and Stehouwer C.D. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 62 (2002) 1402-1407
15. Converse Jr. R.L., Jacobsen T.N., Toto R.D., Jost C.M., Cosentino F., Fouad-Tarazi F., and Victor R.G. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327 (1992) 1912-1918
16. Healey J.S., Baranchuk A., Crystal E., Morillo C.A., Garfinkle M., Yusuf S., and Connolly S.J. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 45 (2005) 1832-1839
17. Ehrlich J.R., Hohnloser S.H., and Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation. Eur Heart J 27 (2006) 512-518
18. Casaclang-Verzosa G., Gersh B.J., and Tsang T.S. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 51 (2008) 1-11
19. Disertori M., Latini R., Barlera S., Franzosi M.G., Staszewsky L., Maggioni A.P., Lucci D., Di Pasquale G., Tognoni G., and GISSI-AF Investigators. Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med 360 (2009) 1606-1617
20. Schmieder R.E., Kjeldsen S.E., Julius S., McInnes G.T., Zanchetti A., and Hua T. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens 26 (2008) 403-411
21. Bader M., Peters J., Baltatu O., Müller D.N., Luft F.C., and Ganten D. Tissue-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79 (2001) 76-102
22. Issac T.T., Dokainish H., and Lakkis N.M. Role of inflammation in initiation and perpetuation of atrial fibrillation. A systematic review of the published data. J Am Coll Cardiol 50 (2007) 2021-2028
23. Boos C.J., Anderson R.A., and Lip Y.H. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
24. Korantzopoulos P., Kolettis T.M., Galaris D., and Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115 (2007) 135-143
25. Eustace J.A., Astor B., Muntner P.M., Ikizler T.A., and Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 65 (2004) 1031-1040